These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10815360)

  • 41. Utility Measures in Pediatric Temporary Health States: Comparison of Prone Positioning Valuation Through 5 Assessment Tools.
    Shahjouei S; Vafaei Sadr A; Khorasani S; Nejat F; Habibi Z; Akbari Sari A
    Value Health Reg Issues; 2019 May; 18():97-105. PubMed ID: 30897544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Population preferences of undergoing brachioplasty for arm laxity.
    Ibrahim AM; Sinno HH; Izadpanah A; Vorstenbosch J; Dionisopoulos T; Lee BT; Lin SJ
    Ann Plast Surg; 2014 Dec; 73 Suppl 2():S149-52. PubMed ID: 25046669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement and comparison of health utility assessments in chronic rhinosinusitis.
    Ference EH; Stubbs V; Lidder AK; Chandra RK; Conley D; Avila PC; Hirsch AG; Min JY; Smith SS; Kern RC; Tan BK
    Int Forum Allergy Rhinol; 2015 Oct; 5(10):929-36. PubMed ID: 26077390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility assessment of body contouring after massive weight loss.
    Sinno H; Thibaudeau S; Tahiri Y; Mok E; Christodoulou G; Lessard L; Williams B; Lin SJ
    Aesthetic Plast Surg; 2011 Oct; 35(5):724-30. PubMed ID: 21487919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility values among myopic patients in mainland China.
    Li S; Wang G; Xu Y; Gray A; Chen G
    Optom Vis Sci; 2014 Jul; 91(7):723-9. PubMed ID: 24901487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S; Norrlid H; Persson U
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting patients' utilities from quality of life items: an improved scoring system for the UBQ-H.
    Martin AJ; Glasziou PP; Simes RJ; Lumley T
    Qual Life Res; 1998 Dec; 7(8):703-11. PubMed ID: 10097619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preference for Alternate-Day Versus Conventional In-Center Dialysis: A Health Utility Elicitation.
    Solimano RJ; Lineen J; Naimark DMJ
    Can J Kidney Health Dis; 2020; 7():2054358120914426. PubMed ID: 32426146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deriving time discounting correction factors for TTO tariffs.
    Attema AE; Brouwer WB
    Health Econ; 2014 Apr; 23(4):410-25. PubMed ID: 23564665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Living up to expectations: Experimental tests of subjective life expectancy as reference point in time trade-off and standard gamble.
    Lipman SA; Brouwer WBF; Attema AE
    J Health Econ; 2020 May; 71():102318. PubMed ID: 32229049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health values of adolescents with cystic fibrosis.
    Yi MS; Britto MT; Wilmott RW; Kotagal UR; Eckman MH; Nielson DW; Kociela VL; Tsevat J
    J Pediatr; 2003 Feb; 142(2):133-40. PubMed ID: 12584533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility assessment to measure the impact of dry eye disease.
    Buchholz P; Steeds CS; Stern LS; Wiederkehr DP; Doyle JJ; Katz LM; Figueiredo FC
    Ocul Surf; 2006 Jul; 4(3):155-61. PubMed ID: 16900272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale.
    Brazier J; Rowen D; Yang Y; Tsuchiya A
    Eur J Health Econ; 2012 Oct; 13(5):575-87. PubMed ID: 21959651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?
    Flood C
    J Ment Health Policy Econ; 2010 Jun; 13(2):65-72. PubMed ID: 20919593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measurement of utility.
    Thavorncharoensap M
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S43-9. PubMed ID: 24964698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chained time trade-off and standard gamble methods. Applications in oesophageal cancer.
    McNamee P; Glendinning S; Shenfine J; Steen N; Griffin SM; Bond J
    Eur J Health Econ; 2004 Feb; 5(1):81-6. PubMed ID: 15452769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility values for specific chronic myeloid leukemia chronic phase health states from the general public in the United Kingdom.
    Guest JF; Gray EJ; Szczudlo T; Magestro M
    Leuk Lymphoma; 2014 Aug; 55(8):1870-5. PubMed ID: 24313831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of time trade-off and quality of life measures in patients with advanced cancer.
    Perez DJ; McGee R; Campbell AV; Christensen EA; Williams S
    Qual Life Res; 1997 Mar; 6(2):133-8. PubMed ID: 9161113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs.
    Bleichrodt H; Johannesson M
    J Health Econ; 1997 Apr; 16(2):155-75. PubMed ID: 10169092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.